Clobazam Suspension
Product Images NDC 59651-401

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 59651-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Clobazam Fig1)

A bar chart showing the percent reduction in weekly drop seizure rate for placebo and three doses (low, medium, high) of Clobazam suspension 2.5 mg/mL. Reduction ranges from about -12.1% for placebo to -68.3% for high dose, with marked statistical significance at medium and high doses. Sample sizes for each group are included.*

FDA Label Image

Figure-10 (Clobazam Fig10)

An instructional photograph depicting a child receiving oral medication via a syringe. An adult hand is administering the dose, with the syringe positioned toward the child's mouth. The image illustrates oral administration technique for suspensions.*

FDA Label Image

Figure-11 (Clobazam Fig11)

Illustration showing a hand gripping the white cap of a bottle of Clobazam oral suspension 2.5 mg/mL. The arrows indicate the cap being twisted open, demonstrating how to open the medication bottle.*

FDA Label Image

Fig12 (Clobazam Fig12)

Label for Clobazam oral suspension 2.5 mg/mL by Aurobindo Pharma Limited. The label indicates the product is for oral administration only, with a 120 mL bottle size. It includes storage instructions, dosage notation, distributor information (Aurobindo Pharma USA, Inc.), and emphasizes shaking the bottle well before use.*

FDA Label Image

Fig13 (Clobazam Fig13)

Label for Clobazam Oral Suspension 2.5 mg/mL by Aurobindo Pharma Limited. The label indicates a 120 mL suspension for oral administration, marked Rx only, with instructions to store in an upright position at controlled room temperature. The packaging includes dosage dispensing information and the distributor's address in East Windsor, NJ, USA. Made in India.*

FDA Label Image

Figure (Clobazam Fig2)

A bar chart depicting the proportion of patients (%) by reduction in weekly drop seizure frequency from baseline (%) across four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. Categories of seizure reduction range from 'Worse' to '80 to 100'. The chart compares seizure reduction outcomes across different Clobazam dose groups and placebo.*

FDA Label Image

Figure-3 (Clobazam Fig3)

Clobazam Oral Suspension 2.5 mg/mL in a 120 mL bottle by Aurobindo Pharma Limited. The image shows the bottle with a white child-resistant cap, a separate bottle adapter, and two oral dosing syringes. The product box is labeled with the NDC 59651-401-12 and specifies oral administration only.*

FDA Label Image

Figure-4 (Clobazam Fig4)

Instructional image showing a hand holding a brown medicine bottle labeled Clobazam Oral Suspension 2.5 mg/mL. The labeler is Aurobindo Pharma Limited. An arrow with the text 'shake well' indicates the bottle should be shaken before use. The dosage form is an oral suspension.*

FDA Label Image

Figure-5 (Clobazam Fig5)

An instructional illustration showing a hand holding a plastic measuring device above the open mouth of a bottle, with an arrow indicating the device is to be inserted or attached to the bottle opening. The image relates to the use of a liquid medication suspension, likely for measuring or administering the dose.*

FDA Label Image

Figure-6 (Clobazam Fig6)

An instructional diagram of an oral dosing syringe labeled with parts including the tip, dosage indicators, edge of the plunger, barrel, and plunger. The syringe is shown horizontally with clear measurement markings on the barrel.*

FDA Label Image

Figure-7 (Clobazam Fig7)

An instructional illustration showing a hand holding a dosing syringe positioned above the open neck of a medicine bottle, indicating the correct way to draw oral suspension medication, possibly Clobazam 2.5 mg/mL, using the syringe.*

FDA Label Image

Figure-4 (Clobazam Fig8)

An instructional illustration showing a bottle with a dropper or syringe attached, demonstrating how to draw liquid medication. The image focuses on the syringe being filled from the bottle, with a downward arrow indicating the direction of the process. It relates to oral administration of a liquid suspension.*

FDA Label Image

Figure-9 (Clobazam Fig9)

An illustration showing the use of an oral dosing syringe to measure liquid medication. The syringe is partially inserted into a bottle, with a close-up of the plunger and measurement markings. An arrow points to the edge of the plunger, indicating where to measure the dose level.*

FDA Label Image

Chemical Structure (Clobazam Str)

Chemical structure diagram of Clobazam, showing its molecular framework including chlorine, nitrogen, and oxygen atoms arranged in a bicyclic compound with attached benzene rings and a methyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.